Novo Nordisk A/S (NYSE:NVO)

147.25
Delayed Data
As of Mar 21
 -0.04 / -0.03%
Today’s Change
95.02
Today|||52-Week Range
147.42
+8.80%
Year-to-Date
Gilead (GILD) Exercises Option to License Nurix's Candidate
Mar 21 / Zacks.com - Paid Partner Content
Pfizer (PFE) Gets FDA Nod for Bivalent COVID Jab in Infants
Mar 15 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights Credit Suisse, Meta Platforms, Novo Nordisk and Salesforce
Mar 21 / Zacks.com - Paid Partner Content
Novo Nordisk (NVO) Follows Lilly, to Cut Insulin Prices by 75%
Mar 15 / Zacks.com - Paid Partner Content
Sanofi's (SNY) Dupixent Gets EU Nod for Eczema in Young Kids
Mar 21 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) Stock Up 5% in a Year: What Awaits in 2023?
Mar 15 / Zacks.com - Paid Partner Content
Universal Health (UHS) Up 26% in 6 Months: More Room to Run?
Mar 20 / Zacks.com - Paid Partner Content
Provention (PRVB) Skyrockets 260% on Buyout Offer From Sanofi
Mar 14 / Zacks.com - Paid Partner Content
Incyte (INCY) Vitiligo Drug Povorcitinib Positive in Phase II
Mar 20 / Zacks.com - Paid Partner Content
Novo Nordisk (NVO) Dips More Than Broader Markets: What You Should Know
Mar 13 / Zacks.com - Paid Partner Content
Merck (MRK) Stock Up 31.6% in a Year: What Awaits in 2023?
Mar 20 / Zacks.com - Paid Partner Content
Pfizer (PFE) Gets FDA Nod for Migraine Nasal Spray Zavzpret
Mar 13 / Zacks.com - Paid Partner Content
Novartis (NVS) Oncology Drug Gets FDA Nod for Label Expansion
Mar 17 / Zacks.com - Paid Partner Content
Roche (RHHBY) Polivy Combo Backed by FDA Advisory Committee
Mar 10 / Zacks.com - Paid Partner Content
Pfizer's (PFE) COVID-19 Drug Paxlovid Gets FDA Panel Vote
Mar 17 / Zacks.com - Paid Partner Content
Neoleukin (NLTX) Up 36% on Initiating Another Restructuring Plan
Mar 10 / Zacks.com - Paid Partner Content
2 Top Healthcare Stocks to Buy for the Long Haul
Mar 17 / MotleyFool.com - Paid Partner Content
AstraZeneca (AZN) Posts Positive Data From Lung Cancer Studies
Mar 10 / Zacks.com - Paid Partner Content
Sanofi (SNY) to Reduce Lantus Insulin Price by Up to 78%
Mar 17 / Zacks.com - Paid Partner Content
Zacks Industry Outlook Highlights J&J, Novo Nordisk, AstraZeneca, Novartis and Sanofi
Mar 10 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: M&A Boom in Drug Industry With PFE & SNY Deals, Other Updates
Mar 17 / Zacks.com - Paid Partner Content
Lilly's (LLY) Alzheimer Drug Fails Late-Stage Prevention Study
Mar 09 / Zacks.com - Paid Partner Content
Novo Nordisk (NVO) Stock Sinks As Market Gains: What You Should Know
Mar 16 / Zacks.com - Paid Partner Content
5 Large Drug Stocks to Watch as Sector Picks Up in 2023
Mar 09 / Zacks.com - Paid Partner Content
Gilead (GILD) Gains 34% in 12 Months: Will the Trend Sustain?
Mar 16 / Zacks.com - Paid Partner Content